C4 Therapeutics, Inc.

NASDAQ:CCCC

2.02 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Operating Activities:
Net Income -34.573-24.666-17.716-28.361-34.754-27.037-35.922-34.78-37.185-31.958-27.412-31.62-15.658-24.683-22.58-20.971-21.795-21.835-10.793-11.912-10.023-10.094-6.991-6.991
Depreciation & Amortization 0.48-2.7342.0452.0271.6910.4470.4580.5450.5210.4150.4350.3050.3230.330.3880.4510.3650.420.4160.4160.4220.4210.6760.676
Deferred Income Tax 0000-20.872-0.472-1.078000000.8470.5580.3720.1022.4853.096000.3410.08200
Stock Based Compensation 8.2358.8316.3816.2156.3598.26.4256.2516.9196.0118.1488.9386.3536.0865.2283.8452.7190.4360.1610.1160.7290.6270.1430.143
Change In Working Capital 7.423-9.2255.8683.3573.403-13.4969.375-6.22-0.66-4.208-5.668-6.243-18.15-1.162-1.915-8.863-5.812.922-4.705-5.584-2.0670.77742.27142.271
Accounts Receivables 7.239-9.17412.431-1.799-11.30.528-0.50.9450.0150.2220.0633.944-0.8711.368-2.5570.828-0.3434.405-5.2261.303-2.0310.04241.90241.902
Change In Inventory 00001.655-2.6150.9600000-2.9771.7232.584-3.957-2.2883.416-0.917-1.7911.641-0.20700
Change In Accounts Payables -0.1760.59-0.7150.1820.169-0.8371.079-0.138-1.076-1.6930.588-1.1520.76-0.6010.627-1.9650.599-0.5942.562-2.11.162.96400
Other Working Capital 0.36-0.641-5.8484.97414.534-10.5727.836-7.0270.401-2.737-6.319-9.035-15.062-3.652-2.569-3.769-3.778-4.305-1.124-2.996-2.837-2.0220.3690.369
Other Non Cash Items 0.5033.661-2.79710.5320.1641.6511.7451.0791.2771.722.3022.0240.6140.5130.5050.5020.4970.5110.3270.2980.2940.2870.8110.811
Operating Cash Flow -17.932-24.133-4.974-18.118-24.009-30.707-18.997-33.125-29.128-28.02-22.195-26.596-25.671-18.358-18.002-24.934-21.539-14.45-14.594-16.666-10.304-7.936.90936.909
Investing Activities:
Investments In Property Plant And Equipment 0.0040.013-0.1970-0.157-0.6-0.362-0.589-1.49-3.305-0.529-0.172-0.1090-0.747-0.421-0.291-0.2840.109-0.1840.073-0.14-0.641-0.641
Acquisitions Net 0000-32.102-58.325-15.51-54.12-10.774-23.219-33.7570000000000000
Purchases Of Investments -40.784-68.565-67.224-107.748-37.878-31.942-48.641-11.437-56.289-55.106-31.913-76.219-145.416-154.702-61.319-176.303-157.929-31.984-103.9420-64.098000
Sales Maturities Of Investments 54.4568.71455.71554.35269.9890.26764.15165.55767.06378.32565.6772.38786.11254.07594.5114.99410400063.764000
Other Investing Activites 00-11.509-53.39632.10258.32515.5154.1210.77423.21933.757-3.832-59.304-100.62733.181-61.309-0.0010.001-103.94200.06314.89-7.445-7.445
Investing Cash Flow 13.670.162-11.706-53.39631.94557.72515.14853.5319.28419.91433.228-4.004-59.413-100.62732.434-61.73-54.221-32.267-103.833-0.184-0.19814.75-8.086-8.086
Financing Activities:
Debt Repayment 00000-11-0.75-0.750000000000000000
Common Stock Issued 010.2810.13534.08957.67300.00200.7770.2110.2590.262.799-0.469170.501-0.148339.8354.499000.0680.15900
Common Stock Repurchased 0-0.0850-0.1090-0.0160-0.094000000000.016-0.086-0.85100.01-0.025-0.008-0.008
Dividends Paid 000000000000000000000000
Other Financing Activities 0.1120.310.1350.603-0.0010.2630.0040.160.0470.3610.2590.480.4661.053170.501-0.151-145.798-1.914152.2240.156-0.0300.0160.016
Financing Cash Flow 0.11210.5060.13534.58357.672-10.753-0.746-0.6840.0470.3610.2590.480.4660.584170.501-0.151194.0532.499152.2240.1560.0780.1340.0160.016
Other Information:
Effect Of Forex Changes On Cash 00000.0110000000000000000000
Net Change In Cash -4.15-10.022-16.545-36.93165.61916.265-4.59519.722-19.797-7.74511.292-30.12-84.618-118.401184.933-86.815118.293-44.21833.797-16.694-10.4246.98428.83928.839
Cash At End Of Period 58.94263.09273.11489.659126.5964.42548.1652.75533.03352.8360.57549.28379.403164.021282.42297.489184.30466.011110.22976.43293.126103.5596.56628.839